140 related articles for article (PubMed ID: 29617556)
1. A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.
Liu BY; He XY; Xu C; Xu L; Ai SL; Cheng SX; Zhuo RX
Biomacromolecules; 2018 Jul; 19(7):2957-2968. PubMed ID: 29617556
[TBL] [Abstract][Full Text] [Related]
2. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
Liu BY; He XY; Zhuo RX; Cheng SX
J Control Release; 2018 Dec; 291():90-98. PubMed ID: 30339905
[TBL] [Abstract][Full Text] [Related]
3. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
Liu BY; He XY; Zhuo RX; Cheng SX
Nanoscale; 2018 Dec; 10(45):21209-21218. PubMed ID: 30417194
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162
[TBL] [Abstract][Full Text] [Related]
5. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
Liu BY; He XY; Xu C; Ren XH; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23870-23879. PubMed ID: 31257851
[TBL] [Abstract][Full Text] [Related]
6. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.
Khademi Z; Ramezani M; Alibolandi M; Zirak MR; Salmasi Z; Abnous K; Taghdisi SM
Carbohydr Polym; 2022 Sep; 292():119691. PubMed ID: 35725215
[TBL] [Abstract][Full Text] [Related]
7. Facile Strategy To Enhance Specificity and Sensitivity of Molecular Beacons by an Aptamer-Functionalized Delivery Vector.
Xu C; He XY; Peng Y; Dai BS; Liu BY; Cheng SX
Anal Chem; 2020 Jan; 92(2):2088-2096. PubMed ID: 31855408
[TBL] [Abstract][Full Text] [Related]
8. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
[TBL] [Abstract][Full Text] [Related]
9. Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
He XY; Ren XH; Peng Y; Zhang JP; Ai SL; Liu BY; Xu C; Cheng SX
Adv Mater; 2020 Apr; 32(17):e2000208. PubMed ID: 32147886
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy.
Ren XH; He XY; Liu BY; Xu C; Cheng SX
ACS Appl Bio Mater; 2020 Nov; 3(11):7831-7839. PubMed ID: 35019523
[TBL] [Abstract][Full Text] [Related]
11. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
[TBL] [Abstract][Full Text] [Related]
13. A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy.
Ren XH; Xu C; Li LL; Zuo Y; Han D; He XY; Cheng SX
J Control Release; 2022 Mar; 343():645-656. PubMed ID: 35157940
[TBL] [Abstract][Full Text] [Related]
14. An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice.
Toda E; Koiso N; Takebayashi A; Ichikawa M; Kiba T; Osakabe K; Osakabe Y; Sakakibara H; Kato N; Okamoto T
Nat Plants; 2019 Apr; 5(4):363-368. PubMed ID: 30911123
[TBL] [Abstract][Full Text] [Related]
15. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
[TBL] [Abstract][Full Text] [Related]
17. High-efficiency genome editing using a dmc1 promoter-controlled CRISPR/Cas9 system in maize.
Feng C; Su H; Bai H; Wang R; Liu Y; Guo X; Liu C; Zhang J; Yuan J; Birchler JA; Han F
Plant Biotechnol J; 2018 Nov; 16(11):1848-1857. PubMed ID: 29569825
[TBL] [Abstract][Full Text] [Related]
18. PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro.
Zhang H; Bahamondez-Canas TF; Zhang Y; Leal J; Smyth HDC
Mol Pharm; 2018 Nov; 15(11):4814-4826. PubMed ID: 30222933
[TBL] [Abstract][Full Text] [Related]
19. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
20. Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast.
Hryhorowicz M; Grześkowiak B; Mazurkiewicz N; Śledziński P; Lipiński D; Słomski R
Mol Biotechnol; 2019 Mar; 61(3):173-180. PubMed ID: 30560399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]